PEStore

Acquirer

Gilead Sciences

Gilead Sciences appears as the named buyer in 4 recorded transactions between 2015 and 2022, most often in healthcare & life sciences.

Recorded acquisitions4
Median consideration$405m4 of 4 disclosed a value
Largest recorded$470m
Bought from a fundNone recorded

Record

What Gilead Sciences has bought

Every recorded transaction where Gilead Sciences is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.

TargetSectorSold byDateConsideration
MiroBioHealthcare & Life Sciences2022-08-04$405m
Nimbus ApolloHealthcare & Life SciencesNimbus Therapeutics2016-04-04$400m
Epitherapeutics ApSHealthcare & Life Sciences2015-05-06$65m
Phenex Pharmaceuticals AGHealthcare & Life Sciences2015-01-06$470m

Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.

Also buying

Comparable buyers

Other companies acquiring in healthcare & life sciences.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Are you an investor?

Register your mandate and we will send matching opportunities as they arise.

Register a mandate

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works